Criminal Justice

The Bipartisan Transparency for American Taxpayers Act prohibits the use of federal funds to pay claims submitted to the Anti-Weaponization Fund. This fund was established by the Department of Justice on May 18, 2026, and the bill specifically bars any money from being used for these payments. The legislation directly affects the Department of Justice and any individuals or entities seeking reimbursement from this specific fund. By restricting funding sources, the bill aims to prevent taxpayer money from being spent on claims directed to this newly created entity.

This bill permanently bans nitazenes and all structurally related synthetic opioids under federal law, creating a broad definition that covers numerous chemical variations designed to evade current restrictions. It directly affects anyone manufacturing, distributing, or possessing these substances without authorization, including illicit drug producers and users. The key mechanism is a class-wide Schedule I classification that includes specific structural features (like modified benzimidazole rings) and excludes new analogs from legal loopholes. This approach aims to prevent new nitazene variants from entering the illegal market and addresses their role in overdose deaths. Substances previously temporarily banned under similar rules will now be permanently prohibited as of the bill's enactment.

S 1136, the DETERRENCE Act, adds sentencing enhancements for certain federal crimes when committed "knowingly at the direction of or in coordination with a foreign government or an agent of a foreign government." It applies to existing offenses including kidnapping (up to 10 additional years), murder-for-hire (up to 10 years), stalking (up to 10 years for serious cases), attacks on federal officials (up to 10 years), and threats against presidential staff (up to 10 years). The bill does not create new crimes but increases penalties for specific violations where foreign government coordination is proven. It directly affects individuals convicted under these provisions who are found to have acted with foreign government involvement.

HR 1266, the Combating Illicit Xylazine Act, adds xylazine - a veterinary sedative increasingly found in illicit drug mixtures - to Schedule III of the Controlled Substances Act, regulating its use and trafficking. It directly affects veterinarians, animal owners, and manufacturers by allowing xylazine to be legally dispensed for animal use under specific veterinary prescriptions, while prohibiting non-veterinary human use. The bill includes transition periods (60 days for practitioners, 1 year for labeling) to ease compliance for manufacturers and practitioners, and requires the DEA and FDA to expedite necessary applications. It also mandates two congressional reports on xylazine's illicit use and trafficking patterns, and directs the Sentencing Commission to review penalties for offenses involving xylazine.

The SAFE Act creates a new category of "fentanyl-related substances" that would automatically be controlled under Schedule I of the Controlled Substances Act based on specific chemical modifications to fentanyl. This affects anyone involved in the production, distribution, or use of substances meeting this broad definition. The bill establishes a process for removing or rescheduling these substances if they're determined to have less potential for abuse than Schedule I substances, and allows courts to review past convictions involving substances that have since been removed from this category. It also creates new research procedures for Schedule I substances and requires a GAO report analyzing the law's implementation and impact within four years.

HR 6104, the Dark Web Interdiction Act of 2025, creates a new federal offense for knowingly distributing controlled substances via the dark web and establishes the Joint Criminal Opioid and Darknet Enforcement Task Force. The bill mandates a 2-level sentencing increase for such violations and directs the new task force - comprising agencies like the FBI, DEA, and Customs - to disrupt dark web drug marketplaces through coordinated investigations, forensic training, and international collaboration. It requires annual reports on the task force’s activities and a separate report on virtual currency use in drug trafficking. The law applies directly to law enforcement agencies and targets individuals operating or using dark web marketplaces for illicit drug sales, with a 5-year sunset provision.

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This act permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the act, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the act establishes a new, alternative registration process for certain schedule I research. The act also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the act expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.

HR 909, the Crime Victims Fund Stabilization Act of 2025, modifies how funds from the False Claims Act are deposited into the Crime Victims Fund. It specifies that from 2025 through 2029, certain False Claims Act proceeds (specifically those for qui tam plaintiff payments and government damage reimbursements) cannot be deposited into the fund. This change directly affects the composition of the Crime Victims Fund by excluding these specific revenue streams during the specified period. The bill does not create new benefits or alter victim services; it only adjusts fund allocation rules for existing False Claims Act revenues.

S 3076, the Nitazene Control Act, permanently classifies nitazenes and related 2-benzylbenzimidazole opioids as Schedule I controlled substances under the federal Controlled Substances Act. This affects anyone possessing, distributing, or researching these substances, as it bans them without specific exemptions. The bill broadly defines the prohibited substances to cover all structural analogs (including modifications to the molecular structure) and those that activate the mu-opioid receptor. It also removes temporary scheduling for these compounds, making their Schedule I status permanent upon enactment. This policy change aims to prevent new illicit analogs from entering the drug supply and reduce overdose risks linked to these potent synthetic opioids.

Stop Sextortion Act This bill criminalizes threats to distribute child sexual abuse material to intimidate, coerce, extort, or cause substantial emotional distress. This practice is commonly referred to as sextortion . The bill also increases criminal penalties for related offenses that involve the use of child sexual abuse material to intimidate, coerce, extort, or cause substantial emotional distress. Specifically, the bill establishes new federal criminal offenses for threatening to distribute child pornography or a visual depiction of a minor engaging in sexually explicit conduct with intent to intimidate, coerce, extort, or cause substantial emotional distress. An offense, or an attempt or conspiracy to commit the offense, is subject to criminal penalties. Additionally, the bill increases the maximum prison term for various offenses involving the sexual exploitation of children if those offenses involve the use of child pornography or a visual depiction of a minor engaged in sexually explicit conduct with intent to intimidate, coerce, extort, or cause substantial emotional distress.